Exercise has been shown to lead to upregulated systemic DCN in breast cancer patients, but without demonstrating a direct relationship between systemic DCN levels and clinical outcome [23, 24], and in prostate cancer patients, exercise had no direct effect on systemic DCN levels [25, 26, 27]. This evidence concerns the gene DCN and breast cancer.